文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症患者早期中心静脉压测量与死亡率的关联:MIMIC-III数据库分析

[Association between early central venous pressure measurement and mortality in patients with sepsis: a data analysis of MIMIC-III database].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症患者入ICU 6小时内测量CVP与28天死亡率降低相关,CVP可作为早期液体复苏中易获取的安全参数。

基于MIMIC-III v1.4数据库的回顾性队列研究,纳入4 733例成人脓毒症患者,其中1 673例在入ICU 6小时内测量CVP,3 060例为对照。早期CVP测量组28天死亡率显著低于对照组(34.2% vs. 40.7%,P<0.01)。Cox多因素分析显示,以12小时内未测CVP为参照,≤3小时测量CVP与28天死亡率降低独立相关(HR=0.65,95%CI 0.55-0.77,P<0.001)。初始CVP与死亡率呈「U」型关系,提示过高或过低初始CVP均与更差生存相关。

要点

  • 脓毒症患者入ICU 6小时内测量CVP者28天死亡率34.2%,显著低于未早期测量者的40.7%(P<0.01)。
  • 以12小时内未测CVP为参照,≤3小时测量CVP的28天死亡HR=0.65(95%CI 0.55-0.77,P<0.001),4-6小时HR=0.72(95%CI 0.60-0.87,P=0.001)。
  • 初始CVP与死亡率呈「U」型关系,过高或过低初始CVP均与更差生存相关。
  • 早期CVP测量组病情更重(乳酸更高、SOFA评分更高),但28天死亡率仍更低,提示CVP测量可能作为早期液体复苏的安全监测参数。
  • 早期CVP测量组机械通气率和血管活性药物依赖率更高、首日液体入量和液体平衡更多,总住院时间更短但ICU住院时间更长。

适用人群与场景

  • MIMIC-III v1.4数据库中成人脓毒症患者,纳入标准为成人脓毒症诊断;排除标准原文未明确列出。
  • 研究场景为ICU,比较入ICU后6小时内测量CVP与未测量者的结局。

诊断标准与关键阈值

  • 早期测量组定义为入ICU后6小时内进行首次CVP测量;对照组为6小时内未测量CVP者。
  • 亚组按首次CVP测量时间分为≤3小时、4-6小时、7-12小时和12小时内未测量四组。
  • 主要终点为28天死亡率。

处置流程与药物剂量

  • 原文未提及具体CVP目标值或基于CVP的液体复苏方案;仅建议将CVP作为早期液体复苏中可获取的安全参数考虑。
  • 原文未提及药物剂量、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 回顾性队列研究,基于MIMIC-III v1.4数据库,纳入4 733例成人脓毒症患者,单数据库多中心数据。
  • 早期CVP测量组(6小时内,n=1 673)28天死亡率34.2%,对照组(n=3 060)40.7%,P<0.01。
  • Lowess平滑分析显示初始CVP与死亡率呈「U」型关系,过高或过低初始CVP均与更差生存相关。
  • Kaplan-Meier分析:≤3小时测量CVP组累积生存率66.7%,显著高于12小时内未测量组的59.1%(χ2=15.810,校正P<0.001);4-6小时组64.4%(校正P=0.053)和7-12小时组60.3%(校正P>0.999)与未测量组差异无统计学意义。
  • Cox多因素分析(校正性别、年龄、SOFA评分、初始乳酸、肾衰竭、24小时内最高血糖和白细胞计数、最低血小板计数):以12小时内未测CVP为参照,≤3小时测量HR=0.65(95%CI 0.55-0.77,P<0.001),4-6小时HR=0.72(95%CI 0.60-0.87,P=0.001),7-12小时HR=0.80(95%CI 0.66-0.98,P=0.032)。
  • 早期CVP测量组总住院时间更短、ICU住院时间更长,机械通气率和血管活性药物依赖率更高,首日液体入量和液体平衡更多。

证据类型、等级与局限

  • 证据类型:基于MIMIC-III数据库的回顾性队列研究。
  • 局限:回顾性设计、单数据库来源、可能存在未测量混杂因素;早期CVP测量组病情更重(乳酸和SOFA评分更高),提示选择偏倚可能;原文未提及证据等级或推荐强度。

对床旁实践的改变

  • 对脓毒症患者,入ICU后早期(尤其≤3小时)测量CVP可能与28天死亡率降低相关,可考虑将CVP作为早期液体复苏中易获取的安全参数。
  • 初始CVP过高或过低均与更差生存相关,解读CVP时需结合临床,避免仅追求单一数值。
  • 本研究为回顾性观察性研究,不能证明CVP测量本身改善预后,临床决策仍需结合完整复苏方案;原文未提及不适用人群。

指南或共识出处

  • 原文未提及指南或共识名称;研究数据来源为Medical Information Mart for Intensive Care-III v1.4(MIMIC-III v1.4)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the association between early central venous pressure (CVP) measurement and mortality in patients with sepsis.

METHODS: The adult patients with sepsis were identified from the health data of Medical Information Mart for Intensive Care-III v1.4 (MIMIC-III v1.4). Data of all adult patients with sepsis were collected, including gender, age, comorbidities, length of survival, total length of hospital stay and intensive care unit (ICU) stay, sequential organ failure assessment (SOFA) score, vital signs, laboratory test results on the first day, vasoactive agents usage, fluid input, urine output and fluid balance on the first day, need for renal replacement therapy and mechanical ventilation, diagnosis of sepsis, and the time and value of the first CVP measurement in the ICU. Patients were divided into early measurement and control groups based on whether or not they had a CVP measurement within the first 6 hours of ICU stay. According to the time of the first CVP measurement, the patients were subdivided into four subgroups: ≤ 3 hours, 4-6 hours, 7-12 hours and no measurement within 12 hours. The primary endpoint was 28-day mortality. The relationship between initial CVP and mortality was analyzed by Lowess smoothing method. Kaplan-Meier survival analysis and Log-Rank test were performed for univariate analysis. Cox regression analysis was performed for multivariate analysis to estimate the relationship between timeliness of CVP measurement and mortality.

RESULTS: A total of 4 733 sepsis patients were enrolled, 1 673 of whom had CVP measured within 6 hours of admission to the ICU, and the other 3 060 patients served as the control group. There were no differences in demographic characteristics and underlying diseases between the two groups, except that the early CVP measurement group had less underlying renal failure compared with control group. The early CVP measurement group had higher lactic acid (Lac) levels and SOFA scores, indicating worse severity of disease as compared with control group. The 28-day mortality in the early CVP measurement group was significantly lower than that in the control group (34.2% vs. 40.7%, P < 0.01). The early CVP measurement group had shorter length of total hospitalization and longer length of ICU stay, higher rate of mechanical ventilation and vasoactive agents dependent, and more fluid input and fluid balanced in the first day of ICU stay compared with control group. Lowess smoothing analysis showed that a "U"-shaped relationship between initial CVP and mortality was identified, suggesting that too high or too low initial CVP was associated with worse survival. Kaplan-Meier survival analysis showed that compared with the patients without early CVP measurement within 12 hours, the cumulative survival rate of patients with CVP measured within 3 hours was significantly higher (66.7% vs. 59.1%; Log-Rank test: χ2 = 15.810, adjusted P < 0.001); while no significant difference was found in patients with CVP measured between 4 hours and 6 hours and between 7 hours and 12 hours compared with the patients without early CVP measurement within 12 hours (64.4%, 60.3% vs. 59.1%; Log-Rank test: χ2 values were 5.630 and 0.100, and adjusted P values were 0.053 and > 0.999, respectively). Cox multivariate analysis showed that the Cox proportional risk model was established by taking patients without CVP measurement within 12 hours as reference, timely CVP measurement after ICU admission was associated with reduced 28-day mortality of patients with sepsis [≤ 3 hours: hazard ratio (HR) = 0.65, 95% confidence interval (95%CI) was 0.55-0.77, P < 0.001; 4-6 hours: HR = 0.72, 95%CI was 0.60-0.87, P = 0.001; 7-12 hours: HR = 0.80, 95%CI was 0.66-0.98, P = 0.032] after the confounding variables (gender, age, SOFA score, initial Lac, renal failure, maximal blood glucose and white blood cell count, and minimal platelet count within 24 hours) were adjusted.

CONCLUSIONS: Early CVP measurement is associated with decreased 28-day mortality in patients with sepsis. CVP should be considered as a valuable and easily accessible safety parameter during early fluid resuscitation.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen H, Gong S, Shang X, et al. [Association between early central venous pressure measurement and mortality in patients with sepsis: a data analysis of MIMIC-III database]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412745. doi:10.3760/cma.j.cn121430-20201120-00722

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。